(VIANEWS) - Blackrock MuniHoldings New Jersey Quality Fund (MUJ), F.N.B. Corporation (FNB), Pfizer (PFE) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Blackrock MuniHoldings New Jersey Quality Fund (MUJ) | 15.45 | -0.13% | 4.75% | 2021-10-19 23:55:55 |
| 2 | F.N.B. Corporation (FNB) | 12.27 | 1.15% | 4.04% | 2021-10-19 13:42:14 |
| 3 | Pfizer (PFE) | 43.16 | 0.7% | 3.98% | 2021-10-22 15:40:48 |
| 4 | Johnson & Johnson (JNJ) | 163.72 | 0.2% | 2.56% | 2021-10-22 15:39:29 |
| 5 | Avnet (AVT) | 37.84 | -0.55% | 2.52% | 2021-10-22 16:48:06 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Blackrock MuniHoldings New Jersey Quality Fund (MUJ) - Dividend Yield: 4.75%
BlackRock MuniHoldings New Jersey Quality Fund, Inc. is a close ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the fixed income markets of United States. The fund invests primarily in long-term, investment grade municipal obligations exempt from federal income taxes and New Jersey personal income taxes. The fund was formerly known as BlackRock MuniHoldings New Jersey Insured Fund. BlackRock MuniHoldings New Jersey Quality Fund, Inc. was formed in 1998 and is domiciled in United States.
Volume
Today's last reported volume for Blackrock MuniHoldings New Jersey Quality Fund is 18072, 51.22% below its average volume of 37046.
Blackrock MuniHoldings New Jersey Quality Fund's last close was $15.45, 5.1% under its 52-week high of $16.28.
Blackrock MuniHoldings New Jersey Quality Fund's Revenue
Year-on-year quarterly revenue growth declined by 5.5%, now sitting on 30.02M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Blackrock MuniHoldings New Jersey Quality Fund's stock is considered to be overbought (>=80).
Blackrock MuniHoldings New Jersey Quality Fund's Stock Yearly Top and Bottom Value
Blackrock MuniHoldings New Jersey Quality Fund's stock is valued at $15.45 at 20:15 EST, below its 52-week high of $16.28 and way above its 52-week low of $13.50.
Blackrock MuniHoldings New Jersey Quality Fund's Moving Average
Blackrock MuniHoldings New Jersey Quality Fund's worth is below its 50-day moving average of $15.77 and below its 200-day moving average of $15.65.More news about Blackrock MuniHoldings New Jersey Quality Fund.
2. F.N.B. Corporation (FNB) - Dividend Yield: 4.04%
F.N.B. Corporation, a financial holding company, provides a range of financial services primarily to consumers, corporations, governments, and small- to medium-sized businesses. The company operates through three segments: Community Banking, Wealth Management, and Insurance. It offers commercial banking solutions, including corporate and small business banking, investment real estate financing, business credit, capital market, and lease financing services. The company also provides consumer banking products and services, such as deposit products, mortgage and consumer lending services, and mobile and online banking services; and wealth management services comprising personal and corporate fiduciary services comprising administration of decedent and trust estates; securities brokerage and investment advisory services, mutual funds, and annuities; and commercial and personal insurance products, as well as mezzanine financing options for small- to medium-sized businesses. As of December 31, 2019, it operated 369 community banking offices in Pennsylvania, Ohio, Maryland, West Virginia, North Carolina, and South Carolina. F.N.B. Corporation was founded in 1864 and is headquartered in Pittsburgh, Pennsylvania.
Volume
Today's last reported volume for F.N.B. Corporation is 1609080, 33.68% below its average volume of 2426180.
F.N.B. Corporation's last close was $12.13, 12.29% below its 52-week high of $13.83.
The company's growth estimates for the present quarter and the next is 15.4% and 3.6%, respectively.F.N.B. Corporation's Revenue
Year-on-year quarterly revenue growth grew by 13.4%, now sitting on 1.19B for the twelve trailing months.
F.N.B. Corporation's Stock Yearly Top and Bottom Value
F.N.B. Corporation's stock is valued at $12.27 at 20:15 EST, way below its 52-week high of $13.83 and way higher than its 52-week low of $7.06.
F.N.B. Corporation's Moving Average
F.N.B. Corporation's worth is above its 50-day moving average of $11.48 and higher than its 200-day moving average of $12.21.More news about F.N.B. Corporation.
3. Pfizer (PFE) - Dividend Yield: 3.98%
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Volume
Today's last reported volume for Pfizer is 16678900, 48.07% below its average volume of 32116800.
Pfizer's last close was $42.86, 17.35% below its 52-week high of $51.86.
Pfizer's Sales
Pfizer's sales growth is 84.5% for the present quarter and 108.8% for the next. The company's growth estimates for the current quarter and the next is 50% and 150%, respectively.
Pfizer's Revenue
Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Pfizer's stock is considered to be oversold (<=20).
Pfizer's Stock Yearly Top and Bottom Value
Pfizer's stock is valued at $43.16 at 20:15 EST, way under its 52-week high of $51.86 and way above its 52-week low of $32.83.
Pfizer's Moving Average
Pfizer's value is below its 50-day moving average of $43.62 and above its 200-day moving average of $41.71.Previous days news about Pfizer
- FDA review of Pfizer Covid-19 vaccine for kids expected. According to The Wall Street Journal on Friday, 22 October, "U.S. health regulators are expected to weigh in soon on the evidence for giving the Covid-19 vaccine from Pfizer Inc. and BioNTech SE to children 5 to 11 years old.", "In early October, Pfizer and BioNTech asked the FDA to authorize the vaccine for children 5 to 11 years old."
- Pfizer says covid vaccine 91% effective in kids ages 5 to 11. According to Bloomberg Quint on Friday, 22 October, "Outside experts on the FDA's Vaccines and Related Biological Products Advisory Committee will meet to evaluate Pfizer and BioNTech's application for emergency authorization of their Covid vaccine in young children. ", "In its briefing documents, Pfizer also released new safety data from an additional 2,250 children enrolled in the trial as part of an expansion of the study requested by U.S. regulators. "
- Pfizer says Covid-19 vaccine is more than 90% effective in 5- to 11-year-olds. According to MarketWatch on Friday, 22 October, "A Pfizer study tracked 2,268 kids in that age group who got two shots three weeks apart of either a placebo or the low-dose vaccine. ", "The CDC reported earlier this week that even as the delta mutant surged between June and September, Pfizer vaccinations were 93% effective at preventing hospitalizations among 12- to 18-year-olds."
- Benefits of Pfizer child shot likely outweigh risks, FDA says. According to Bloomberg Quint on Saturday, 23 October, "A poll conducted by the Kaiser Family Foundation in September, before Pfizer first revealed results from its trial of the 5-11 vaccine, found only about 34% of parents would vaccinate their kids right away when a shot was authorized for the age group.", "The FDA also posted documents from Pfizer on Friday in which the drug company said that the reduced-dose vaccine was 90.7% effective at preventing symptomatic disease in kids in a study."
More news about Pfizer.
4. Johnson & Johnson (JNJ) - Dividend Yield: 2.56%
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Volume
Today's last reported volume for Johnson & Johnson is 4051610, 30.79% below its average volume of 5854250.
Johnson & Johnson's last close was $163.40, 9.18% under its 52-week high of $179.92.
The company's growth estimates for the present quarter and the next is 7.3% and 19.9%, respectively.Johnson & Johnson's Revenue
Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 89.19B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Johnson & Johnson's stock is considered to be oversold (<=20).
Johnson & Johnson's Stock Yearly Top and Bottom Value
Johnson & Johnson's stock is valued at $163.72 at 20:15 EST, below its 52-week high of $179.92 and way higher than its 52-week low of $133.65.
Johnson & Johnson's Moving Average
Johnson & Johnson's worth is below its 50-day moving average of $163.98 and below its 200-day moving average of $167.35.More news about Johnson & Johnson.
5. Avnet (AVT) - Dividend Yield: 2.52%
Avnet, Inc., a technology solutions company, markets, sells, and distributes electronic components. The company operates through two segments, Electronic Components and Farnell. The Electronic Components segment markets, sells, and distributes semiconductors; interconnect, passive, and electromechanical devices; and other integrated components from electronic component manufacturers. It also offers design chain support that provides engineers with technical design solutions; engineering and technical resources to support product design, bill of materials development, and technical education and training; and supply chain solutions that provide support and logistical services to original equipment manufacturers, electronic manufacturing service providers, and electronic component manufacturers. In addition, this segment provides integrated solutions, such as technical design, integration, and assembly of embedded products, and systems and solutions primarily for industrial applications, as well as for intelligent embedded and innovative embedded display solutions comprising touch and passive displays. Further, it develops and manufactures standard board and industrial subsystems, and application-specific devices that enable it to produce systems tailored to specific customer requirements. This segment serves various markets, such as automotive, medical, defense, aerospace, telecommunications, industrial, and digital editing. The Farnell segment distributes kits, tools, and electronic and industrial automation components, as well as test and measurement products to engineers and entrepreneurs. It has operations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Avnet, Inc. was founded in 1921 and is headquartered in Phoenix, Arizona.
Volume
Today's last reported volume for Avnet is 465155, 19.75% below its average volume of 579623.
Avnet's last close was $38.05, 16.24% below its 52-week high of $45.43.
The company's growth estimates for the present quarter and the next is 200% and 127.1%, respectively.Avnet's Revenue
Year-on-year quarterly revenue growth grew by 25.7%, now sitting on 19.53B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Avnet's stock is considered to be oversold (<=20).
Avnet's Stock Yearly Top and Bottom Value
Avnet's stock is valued at $37.84 at 20:15 EST, way under its 52-week high of $45.43 and way higher than its 52-week low of $24.30.
Avnet's Moving Average
Avnet's worth is above its 50-day moving average of $37.69 and under its 200-day moving average of $40.85.More news about Avnet.